Neuren Pharmaceuticals
NEU.AX
$13.49
Share price
2.08%
Change (1 day)
-41.76%
Change (1 year)
Categories
Operating Margin for Neuren Pharmaceuticals (NEU.AX)
Operating Margin at the end of 2023: 88.45%
According to Neuren Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is 88.45%. At the end of 2023 the company had an Operating Margin of 88.45%.
Operating Margin history for Neuren Pharmaceuticals from 2002 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2023 | 88.45% | 6895.8% |
| 2022 | 1.26% | |
| 2018 | 22.69% | |
| 2010 | -107.37% | 20010.14% |
| 2009 | -0.53% | -99.92% |
| 2008 | -675.29% | -47.54% |
| 2007 | -1,287.13% | -77.99% |
| 2006 | -5,848.45% | 203.1% |
| 2005 | -1,929.57% | 413.9% |
| 2004 | -375.47% | 88.55% |
| 2003 | -199.14% | -22.6% |
| 2002 | -257.29% |
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.